INNV
InnovAge Holding Corp.
Medical - Care Facilities
Market Cap$1.10B
5Y Perf.-68.7%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
INNV vs CCRN vs ALHC vs AMN
Revenue, margins, valuation, and 5-year total return — side by side.
CCRN
Cross Country Healthcare, Inc.
Medical - Care Facilities
Market Cap$423M
5Y Perf.+4.8%
ALHC
Alignment Healthcare, Inc.
Medical - Healthcare Plans
Market Cap$3.73B
5Y Perf.-16.8%
AMN
AMN Healthcare Services, Inc.
Medical - Care Facilities
Market Cap$869M
5Y Perf.-69.5%
INNV vs CCRN vs ALHC vs AMN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | INNV | CCRN | ALHC | AMN |
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Healthcare Plans | Medical - Care Facilities |
| Market Cap | $1.10B | $423M | $3.73B | $869M |
| Revenue (TTM) | $946M | $761M | $4.26B | $3.42B |
| Net Income (TTM) | $-22M | $-99M | $20M | $-32M |
| Gross Margin | 14.8% | 18.2% | 9.0% | 25.5% |
| Operating Margin | 1.5% | -0.9% | 0.8% | 0.3% |
| Forward P/E | 32.0x | 133.8x | 140.9x | 11.0x |
| Total Debt | $101M | $2M | $338M | $803M |
| Cash & Equiv. | $64M | $109M | $578M | $34M |
INNV vs CCRN vs ALHC vs AMN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
INNV
CCRN
ALHC
AMN
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| InnovAge Holding Co… (INNV) | 100 | 31.3 | -68.7% |
| Cross Country Healt… (CCRN) | 100 | 104.8 | +4.8% |
| Alignment Healthcar… (ALHC) | 100 | 83.2 | -16.8% |
| AMN Healthcare Serv… (AMN) | 100 | 30.5 | -69.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INNV vs CCRN vs ALHC vs AMN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ALHC leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. InnovAge Holding Corp. is the stronger pick specifically for recent price momentum and sentiment. AMN also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
INNV
InnovAge Holding Corp.
The Momentum Pick
INNV is the #2 pick in this set and the best alternative if momentum is your priority.
- +147.9% vs CCRN's -5.4%
Best for: momentum
CCRN
Cross Country Healthcare, Inc.
The Income Pick
CCRN is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.78
- Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
Best for: income & stability and sleep-well-at-night
ALHC
Alignment Healthcare, Inc.
The Insurance Pick
ALHC carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
- 5.4% 10Y total return vs CCRN's -10.5%
- Beta 0.75, current ratio 1.74x
- 46.1% revenue growth vs CCRN's -21.6%
Best for: growth exposure and long-term compounding
AMN
AMN Healthcare Services, Inc.
The Value Play
AMN is the clearest fit if your priority is value.
- Lower P/E (11.0x vs 140.9x)
Best for: value
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ALHC | 46.1% revenue growth vs CCRN's -21.6% |
| Value | AMN | Lower P/E (11.0x vs 140.9x) |
| Quality / Margins | ALHC | 0.5% margin vs CCRN's -13.0% |
| Stability / Safety | ALHC | Beta 0.75 vs INNV's 1.66 |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | INNV | +147.9% vs CCRN's -5.4% |
| Efficiency (ROA) | ALHC | 1.8% ROA vs CCRN's -19.8% |
INNV vs CCRN vs ALHC vs AMN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2023
FY 2025
INNV vs CCRN vs ALHC vs AMN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLALHCLAGGINGINNV
Who Leads Where
AMN leads in 2 of 6 categories
ALHC leads 2 • CCRN leads 1 • INNV leads 0 • 1 tied
Explore the data ↓INNVInnovAge Holding Corp.
0leads
CCRNCross Country Healthc…
1leads
AMNAMN Healthcare Servic…
2leads
ALHCAlignment Healthcare,…
2leads
6 Total Categories
CATEGORYLEADERvs AMNvs CCRNMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
AMN4/6
Valuation MetricsMultiples, price ratios, and targets
AMN4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ALHC5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
ALHC3/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
CCRN1/1
Income & Cash Flow (Last 12 Months)
AMN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALHC is the larger business by revenue, generating $4.3B annually — 5.6x CCRN's $761M. ALHC is the more profitable business, keeping 0.5% of every revenue dollar as net income compared to CCRN's -13.0%. On growth, AMN holds the edge at +99.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | INNVInnovAge Holding … | CCRNCross Country Hea… | ALHCAlignment Healthc… | AMNAMN Healthcare Se… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $946M | $761M | $4.3B | $3.4B |
| EBITDAEarnings before interest/tax | $4M | $9M | $66M | $127M |
| Net IncomeAfter-tax profit | -$22M | -$99M | $20M | -$32M |
| Free Cash FlowCash after capex | $39M | $41M | $237M | $714M |
| Gross MarginGross profit ÷ Revenue | +14.8% | +18.2% | +9.0% | +25.5% |
| Operating MarginEBIT ÷ Revenue | +1.5% | -0.9% | +0.8% | +0.3% |
| Net MarginNet income ÷ Revenue | -2.3% | -13.0% | +0.5% | -0.9% |
| FCF MarginFCF ÷ Revenue | +4.1% | +5.4% | +5.6% | +20.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.5% | -100.0% | +33.3% | +99.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -161.3% | -6.0% | +2.1% | +56.8% |
AMN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
AMN leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, AMN's 8.6x EV/EBITDA is more attractive than ALHC's 77.1x.
| Metric | INNVInnovAge Holding … | CCRNCross Country Hea… | ALHCAlignment Healthc… | AMNAMN Healthcare Se… |
|---|---|---|---|---|
| Market CapShares × price | $1.1B | $423M | $3.7B | $869M |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $317M | $3.5B | $1.6B |
| Trailing P/EPrice ÷ TTM EPS | -36.73x | -4.47x | -4932.43x | -9.06x |
| Forward P/EPrice ÷ next-FY EPS est. | 32.03x | 133.84x | 140.93x | 11.05x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 23.75x | 77.12x | 8.63x |
| Price / SalesMarket cap ÷ Revenue | 1.28x | 0.40x | 0.94x | 0.32x |
| Price / BookPrice ÷ Book value/share | 4.16x | 1.31x | 20.16x | 1.35x |
| Price / FCFMarket cap ÷ FCF | 41.22x | 10.55x | 32.95x | 3.72x |
AMN leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
ALHC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ALHC delivers a 11.5% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-27 for CCRN. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALHC's 1.89x. On the Piotroski fundamental quality scale (0–9), INNV scores 6/9 vs AMN's 5/9, reflecting solid financial health.
| Metric | INNVInnovAge Holding … | CCRNCross Country Hea… | ALHCAlignment Healthc… | AMNAMN Healthcare Se… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.2% | -27.1% | +11.5% | -5.0% |
| ROA (TTM)Return on assets | -4.1% | -19.8% | +1.8% | -1.4% |
| ROICReturn on invested capital | -6.8% | -0.9% | — | +1.6% |
| ROCEReturn on capital employed | -7.1% | -0.8% | +2.9% | +2.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.38x | 0.01x | 1.89x | 1.25x |
| Net DebtTotal debt minus cash | $37M | -$106M | -$240M | $769M |
| Cash & Equiv.Liquid assets | $64M | $109M | $578M | $34M |
| Total DebtShort + long-term debt | $101M | $2M | $338M | $803M |
| Interest CoverageEBIT ÷ Interest expense | 5.96x | -1.39x | 1.27x | -1.70x |
ALHC leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
ALHC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CCRN five years ago would be worth $7,746 today (with dividends reinvested), compared to $2,488 for AMN. Over the past 12 months, INNV leads with a +147.9% total return vs CCRN's -5.4%. The 3-year compound annual growth rate (CAGR) favors ALHC at 36.2% vs AMN's -37.1% — a key indicator of consistent wealth creation.
| Metric | INNVInnovAge Holding … | CCRNCross Country Hea… | ALHCAlignment Healthc… | AMNAMN Healthcare Se… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | +55.7% | +62.4% | -9.7% | +48.7% |
| 1-Year ReturnPast 12 months | +147.9% | -5.4% | +17.6% | +14.6% |
| 3-Year ReturnCumulative with dividends | +24.5% | -44.3% | +152.4% | -75.1% |
| 5-Year ReturnCumulative with dividends | -68.5% | -22.5% | -22.7% | -75.1% |
| 10-Year ReturnCumulative with dividends | -66.6% | -10.5% | +5.4% | -41.5% |
| CAGR (3Y)Annualised 3-year return | +7.6% | -17.7% | +36.2% | -37.1% |
ALHC leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — ALHC and AMN each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALHC is the less volatile stock with a 0.75 beta — it tends to amplify market swings less than INNV's 1.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMN currently trades 94.7% from its 52-week high vs INNV's 75.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | INNVInnovAge Holding … | CCRNCross Country Hea… | ALHCAlignment Healthc… | AMNAMN Healthcare Se… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.66x | 0.78x | 0.75x | 1.08x |
| 52-Week HighHighest price in past year | $10.68 | $14.99 | $23.87 | $23.74 |
| 52-Week LowLowest price in past year | $2.85 | $7.43 | $11.63 | $14.87 |
| % of 52W HighCurrent price vs 52-week peak | +75.7% | +87.3% | +76.5% | +94.7% |
| RSI (14)Momentum oscillator 0–100 | 50.2 | 53.1 | 37.3 | 57.2 |
| Avg Volume (50D)Average daily shares traded | 291K | 552K | 3.6M | 849K |
Evenly matched — ALHC and AMN each lead in 1 of 2 comparable metrics.
Analyst Outlook
CCRN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: INNV as "Hold", CCRN as "Hold", ALHC as "Buy", AMN as "Buy". Consensus price targets imply 36.1% upside for ALHC (target: $25) vs -18.9% for CCRN (target: $11).
| Metric | INNVInnovAge Holding … | CCRNCross Country Hea… | ALHCAlignment Healthc… | AMNAMN Healthcare Se… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $6.80 | $10.61 | $24.83 | $22.50 |
| # AnalystsCovering analysts | 8 | 14 | 16 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | +1.6% | 0.0% | +0.2% |
CCRN leads this category, winning 1 of 1 comparable metric.
Key Takeaway
AMN leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). ALHC leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.
Best OverallAlignment Healthcare, Inc. (ALHC)Leads 2 of 6 categories
Loading custom metrics...
INNV vs CCRN vs ALHC vs AMN: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is INNV or CCRN or ALHC or AMN a better buy right now?
For growth investors, Alignment Healthcare, Inc.
(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Analysts rate Alignment Healthcare, Inc. (ALHC) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — INNV or CCRN or ALHC or AMN?
Over the past 5 years, Cross Country Healthcare, Inc.
(CCRN) delivered a total return of -22. 5%, compared to -75. 1% for AMN Healthcare Services, Inc. (AMN). Over 10 years, the gap is even starker: ALHC returned +5. 4% versus INNV's -66. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — INNV or CCRN or ALHC or AMN?
By beta (market sensitivity over 5 years), Alignment Healthcare, Inc.
(ALHC) is the lower-risk stock at 0. 75β versus InnovAge Holding Corp. 's 1. 66β — meaning INNV is approximately 122% more volatile than ALHC relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 189% for Alignment Healthcare, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — INNV or CCRN or ALHC or AMN?
By revenue growth (latest reported year), Alignment Healthcare, Inc.
(ALHC) is pulling ahead at 46. 1% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — INNV or CCRN or ALHC or AMN?
Alignment Healthcare, Inc.
(ALHC) is the more profitable company, earning -0. 0% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps -0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMN leads at 1. 2% versus -3. 5% for INNV. At the gross margin level — before operating expenses — INNV leads at 68. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is INNV or CCRN or ALHC or AMN more undervalued right now?
On forward earnings alone, AMN Healthcare Services, Inc.
(AMN) trades at 11. 0x forward P/E versus 140. 9x for Alignment Healthcare, Inc. — 129. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALHC: 36. 1% to $24. 83.
07Which pays a better dividend — INNV or CCRN or ALHC or AMN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is INNV or CCRN or ALHC or AMN better for a retirement portfolio?
For long-horizon retirement investors, Alignment Healthcare, Inc.
(ALHC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 75)). InnovAge Holding Corp. (INNV) carries a higher beta of 1. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALHC: +5. 4%, INNV: -66. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between INNV and CCRN and ALHC and AMN?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: INNV is a small-cap quality compounder stock; CCRN is a small-cap quality compounder stock; ALHC is a small-cap high-growth stock; AMN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(INNV: 15.5% · CCRN: -100.0%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.